Howdy traders, it’s Bryce here.
There’s a very important ticker you need to watch right now …Â
It spiked Monday morning and managed to climb over 3,400% in premarket trading hours.
If that sounds completely insane, you’re on the right track.
Normal stocks don’t move like this. And even though we expect that kind of volatility from the small-cap market, the spikes aren’t always this quick.
They’re also usually not as big and they rarely happen in premarket hours.
All of this should tell you something …Â
There is an unprecedented opportunity in the market right now.
And here’s the good news …Â
If you missed yesterday’s spike there’s still time.
We usually see these big runners offer multiple trade setups over several days. That’s why Monday’s +3,400% runner is at the top of my watchlist all week.
Let’s go through everything you need to know …Â
Top Watch This Week
On Monday morning, Vistagen Therapeutics Inc. (NASDAQ: VTGN) announced positive results from a social anxiety nasal spray.
It’s credible news that has a lot of momentum behind it.
Plus, the stock’s float is only 7 million shares. That’s well below our goal of a 10 million share stock (the low supply drives prices when demand increases).
It’s also a biotech stock, and the biotech sector is host to a lot of bullish volatility right now.
It’s a perfect storm.
And there’s something else to keep an eye on …Â
Sympathy Plays
A huge runner like this often sends ripples through the market.
We’ll likely see similar biotech stocks spike due to hype and greed.
So if you don’t want to trade the OG runner, keep an eye out for related biotechs with momentum.
Tim Bohen called the play on VTGN.
It was in his pre-market webinar with a bunch of other traders. Anybody that signed in could have snagged some profits.
He does these webinars every morning and another at noon.
Click here for the hottest stocks and daily trade plans.
Take it from me, I’ve been where you are …Â
The fastest way to improve is live instruction.
Tim Bohen can set you on the right road every day.
See you in the next letter.